NC
EDIT icon

NewSquare Capital’s Editas Medicine EDIT Stock Holding History

NewSquare Capital’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-30
Closed -$223 – 382
2024
Q1 		$223 Hold
30
– – ﹤0.01% 402
2023
Q4 		$304 Hold
30
– – ﹤0.01% 446
2023
Q3 		$234 Sell
30
-180
-86% -$1.54K ﹤0.01% 550
2023
Q2 		$1.73K Hold
210
– – ﹤0.01% 539
2023
Q1 		$1.52K Buy
210
+60
+40% +$533 ﹤0.01% 597
2022
Q4 		$1.33K Buy
+150
New +$1.65K ﹤0.01% 542

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

NewSquare Capital's EDIT Position: Q2 2024 in Review

NewSquare Capital sold out of Editas Medicine (EDIT) in Q2 2024, closing a stake of 30 shares — an estimated $223 sold.

NewSquare Capital first reported a position in EDIT in Q4 2022 and held it in 6 quarters. The position peaked at $1.73K in Q2 2023. 235 funds tracked by Wall St. Rank hold EDIT as of Q2 2024.

  • NewSquare Capital reported no remaining Editas Medicine position as of Q2 2024 after selling out during the quarter.
  • NewSquare Capital sold 30 Editas Medicine shares in Q2 2024, an estimated $223.
  • NewSquare Capital first reported a position in Editas Medicine in Q4 2022 and held it in 6 quarters.
  • NewSquare Capital's Editas Medicine position peaked at $1.73K in Q2 2023.
  • 235 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2024.

Based on NewSquare Capital's 13F filing for Q2 2024, filed 23 Jul 2024.